Global Insomnia Market Overview:
Global Insomnia Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Insomnia Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Insomnia involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Insomnia Market:
The Insomnia Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Insomnia Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Insomnia Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Insomnia market has been segmented into:
Pharmacological therapy and Non Pharmacological therapy
By Application, Insomnia market has been segmented into:
Capsules
Tablet and others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Insomnia market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Insomnia market.
Top Key Players Covered in Insomnia market are:
Vanda Pharmaceuticals Inc. (US.)
Neurim (Switzerland)
Eisai
Co. (Japan)
Purdue Pharma LP (US.)
Merck & Co Inc(US.)
Pfizer
Inc. (US.)
Astellas (UK.)
Flynn Pharma (UK.)
Takeda Pharmaceutical Company(Japan)
SkyePharma (UK.)
Meda Consumer Healthcare Inc (US.)
Sanofi (France)
among others
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Insomnia Market Type
4.1 Insomnia Market Snapshot and Growth Engine
4.2 Insomnia Market Overview
4.3 Pharmacological therapy and Non Pharmacological therapy
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Pharmacological therapy and Non Pharmacological therapy: Geographic Segmentation Analysis
Chapter 5: Insomnia Market Application
5.1 Insomnia Market Snapshot and Growth Engine
5.2 Insomnia Market Overview
5.3 Capsules
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Capsules: Geographic Segmentation Analysis
5.4 Tablet and others
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Tablet and others: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Insomnia Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 VANDA PHARMACEUTICALS INC. (US.)
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 NEURIM (SWITZERLAND)
6.4 EISAI
6.5 CO. (JAPAN)
6.6 PURDUE PHARMA LP (US.)
6.7 MERCK & CO INC(US.)
6.8 PFIZER
6.9 INC. (US.)
6.10 ASTELLAS (UK.)
6.11 FLYNN PHARMA (UK.)
6.12 TAKEDA PHARMACEUTICAL COMPANY(JAPAN)
6.13 SKYEPHARMA (UK.)
6.14 MEDA CONSUMER HEALTHCARE INC (US.)
6.15 SANOFI (FRANCE)
6.16 AMONG OTHERS
Chapter 7: Global Insomnia Market By Region
7.1 Overview
7.2. North America Insomnia Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Pharmacological therapy and Non Pharmacological therapy
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Capsules
7.2.3.2 Tablet and others
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Insomnia Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Pharmacological therapy and Non Pharmacological therapy
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Capsules
7.3.3.2 Tablet and others
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Insomnia Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Pharmacological therapy and Non Pharmacological therapy
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Capsules
7.4.3.2 Tablet and others
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Insomnia Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Pharmacological therapy and Non Pharmacological therapy
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Capsules
7.5.3.2 Tablet and others
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Insomnia Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Pharmacological therapy and Non Pharmacological therapy
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Capsules
7.6.3.2 Tablet and others
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Insomnia Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Pharmacological therapy and Non Pharmacological therapy
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Capsules
7.7.3.2 Tablet and others
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Insomnia Scope:
|
Report Data
|
Insomnia Market
|
|
Insomnia Market Size in 2025
|
USD XX million
|
|
Insomnia CAGR 2025 - 2032
|
XX%
|
|
Insomnia Base Year
|
2024
|
|
Insomnia Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Vanda Pharmaceuticals Inc. (US.), Neurim (Switzerland), Eisai, Co. (Japan), Purdue Pharma LP (US.), Merck & Co Inc(US.), Pfizer, Inc. (US.), Astellas (UK.), Flynn Pharma (UK.), Takeda Pharmaceutical Company(Japan), SkyePharma (UK.), Meda Consumer Healthcare Inc (US.), Sanofi (France), among others.
|
|
Key Segments
|
By Type
Pharmacological therapy and Non Pharmacological therapy
By Applications
Capsules
Tablet and others
|
